Technical Analysis for BOLD - Audentes Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 37.68 -5.66% -2.26
BOLD closed down 5.66 percent on Wednesday, May 22, 2019, on 48 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical BOLD trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Bollinger Band Squeeze Range Contraction -5.66%
BB Squeeze Started Range Contraction -5.66%
20 DMA Support Bullish -2.89%
50 DMA Support Bullish -2.89%
MACD Bullish Signal Line Cross Bullish -2.89%

Older signals for BOLD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Audentes Therapeutics, Inc. is a biotechnology company which focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases. The company's product pipeline consists of AT132 for the treatment of X-linked myotubular myopathy; AT342 for the treatment of crigler-najjar syndrome type 1; AT307 for the treatment of the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia and AT982 for the treatment of pompe disease, which are in pre-clinical trial stage. Audentes Therapeutics, Inc. is based in San Francisco, California.
Biotechnology Medical Specialties Organ Systems Rare Diseases Gene Therapy Hepatology Cardiac Arrhythmia Gene Therapy Products Pompe Disease Channelopathies Myopathy Treatment Of Pompe Disease
Is BOLD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 46.18
52 Week Low 17.95
Average Volume 512,616
200-Day Moving Average 31.1284
50-Day Moving Average 38.497
20-Day Moving Average 38.3495
10-Day Moving Average 38.482
Average True Range 1.9324
ADX 12.09
+DI 18.4682
-DI 19.7449
Chandelier Exit (Long, 3 ATRs ) 35.6728
Chandelier Exit (Short, 3 ATRs ) 40.7972
Upper Bollinger Band 40.3859
Lower Bollinger Band 36.3131
Percent B (%b) 0.34
BandWidth 10.620217
MACD Line 0.1714
MACD Signal Line 0.1804
MACD Histogram -0.009
Fundamentals Value
Market Cap 1.05 Billion
Num Shares 27.8 Million
EPS -3.52
Price-to-Earnings (P/E) Ratio -10.70
Price-to-Sales 0.00
Price-to-Book 4.35
PEG Ratio -1.48
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 41.34
Resistance 3 (R3) 41.68 40.81 40.73
Resistance 2 (R2) 40.81 39.87 40.64 40.53
Resistance 1 (R1) 39.24 39.30 38.81 38.90 40.32
Pivot Point 38.37 38.37 38.15 38.20 38.37
Support 1 (S1) 36.80 37.43 36.37 36.46 35.04
Support 2 (S2) 35.93 36.86 35.76 34.83
Support 3 (S3) 34.36 35.93 34.63
Support 4 (S4) 34.02